Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine-Reference-Cited by-同舟云学术

Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine

Published:2021 Issue:1 Volume:10 Page:24
ISSN:2287-3651
Container-title:Clinical and Experimental Vaccine Research
language:en
Short-container-title:Clin Exp Vaccine Res

Author:

Ghalavand Majdedin¹²^ORCID,Saadati Mojtaba³^ORCID,Salimian Jafar⁴^ORCID,Abbasi Ebrahim⁵^ORCID,Hosseinzadeh Ghader⁶^ORCID,Gouvarchin Ghaleh Hadi Esmaeili²^ORCID,Ahmadi Ali⁷^ORCID

Affiliation:

1. Student Research Committee, Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2. Applied Virology Research Center, Baqiyatallah University of Medical Science, Tehran, Iran.

3. Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.

4. Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Science, Tehran, Iran.

5. Razi Vaccine and Serum Research Institute, Karaj, Iran.

6. Department of Polymer Science and Engineering, University of Bonab, Bonab, Iran.

7. Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Science, Tehran, Iran.

Publisher

Korean Vaccine Society

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pharmacology,Immunology and Allergy

Link

https://ecevr.org/pdf/10.7774/cevr.2021.10.1.24

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of chitosan and its modified derivatives as vaccine adjuvant: A review;Carbohydrate Polymer Technologies and Applications;2024-12

2. Tailoring biomaterials for vaccine delivery;Journal of Nanobiotechnology;2024-08-12

3. Recent Progress of Chitosan Nanoparticles for the Development of Superior Delivery of Vaccines;Discovery Medicine;2024

4. Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models;Molecular Immunology;2022-09

5. Biopolymers and Osmolytes — A Focus towards the Prospects of Stability and Adjuvanticity of Vaccines;Macromolecular Research;2022-06-22